JNJ - Latest News
Johnson & Johnson (JNJ), operates in Healthcare / Drug Manufacturers - General, trades on NYSE.
Market capitalization stands near $554.67B. Trailing twelve-month P/E ratio is 26.78. Beta to the broader market is 0.26.
The article list below shows the most recent JNJ headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent JNJ Headlines
Why Keeping Emergency Cash in Checking Costs You $15,000 Over a Decade
247wallst.com - May 15, 2026
On episode 168 of the Rich Habits Podcast, co-host Robert Croak made a pitch that sounds almost too easy to be a strategy. He noted, "The easiest str
Congressman A Big Fan Of Dividend Reinvestments: Here's His Core Blue Chip Stocks
benzinga.com - May 15, 2026
Tracking the trading activity of members of Congress can reveal unusual timed purchases based on congressional committees and world events. For one m
One Blue-Chip Stock Is Up 11% While the S&P 500 Struggles
benzinga.com - May 15, 2026
The S&P 500 has had a rough 2026. Johnson & Johnson has not.
How Important Are Skyrizi and Rinvoq to AbbVie's Q1 Results?
zacks.com - May 15, 2026
ABBV's Q1 beat is powered by Skyrizi and Rinvoq, whose strong sales growth offset Humira declines and boosts 2026 guidance.
Groundbreaking global survey captures the significant patient burden experienced with current standard-of-care bladder cancer treatments, underscoring urgency for continued innovation
prnewswire.com - May 14, 2026
More than 90% of patients surveyed who underwent bladder removal or received BCG report negative impact on most aspects of their lives Among patients
How News Affects JNJ Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track JNJ's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked JNJ news questions
- What is the latest JNJ news headline?
- The most recent JNJ headline (May 15, 2026) is "Why Keeping Emergency Cash in Checking Costs You $15,000 Over a Decade". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the JNJ news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What JNJ news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual JNJ options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.